COMPASS Pathways Investor Relations Material
Latest events
Q1 2025
COMPASS Pathways
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from COMPASS Pathways Plc
Access all reports
COMPASS Pathways Plc is a mental health care company developing psychedelic-based therapies for the treatment of mental health disorders. The company focuses on clinical research and development of psilocybin-assisted therapies for conditions such as treatment-resistant depression. The company is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
CMPS
Country
🇺🇸 United States